Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析

◆英語タイトル:Immune Pharmaceuticals Inc (IMNP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH368144FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Immune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designed to block the protein eotaxin-1 which causes various diseases. Immune Pharma’s Nanocyclo is a nanoformulation of cyclosporine which enables the molecule to penetrate into the skin layers and provide local anti-inflammatory effect. The company also provides Crolibulin and Azixa, a novel small molecule vascular disrupting agent developed for the treatment of patients with solid tumors, primary brain cancers and metastatic tumors. Its products are used to treat bullous pemphigoid, ulcerative colitis, atopic dermatitis, psoriasis, and other inflammatory conditions. Immune Pharma develops drugs in the areas of immuno-oncology, nano-dermatology and neuropathic pain. The company has operations in the US and Israel. Immune Pharma is headquartered in Englewood Cliffs, New Jersey, the US.

Immune Pharmaceuticals Inc Key Recent Developments

Mar 18,2021: Immune Pharmaceuticals announces immune pharmaceuticals proposal to exit bankruptcy

This comprehensive SWOT profile of Immune Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immune Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Immune Pharmaceuticals Inc – Key Information
Immune Pharmaceuticals Inc – Overview
Immune Pharmaceuticals Inc – Key Employees
Immune Pharmaceuticals Inc – Key Employee Biographies
Immune Pharmaceuticals Inc – Key Operational Heads
Immune Pharmaceuticals Inc – Major Products and Services
Immune Pharmaceuticals Inc – History
Immune Pharmaceuticals Inc – Company Statement
Immune Pharmaceuticals Inc – Locations And Subsidiaries
Immune Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Immune Pharmaceuticals Inc – Business Description
Immune Pharmaceuticals Inc – Corporate Strategy
Immune Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Immune Pharmaceuticals Inc – Strengths
Immune Pharmaceuticals Inc – Weaknesses
Immune Pharmaceuticals Inc – Opportunities
Immune Pharmaceuticals Inc – Threats
Immune Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Immune Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Immune Pharmaceuticals Inc, Key Information
Immune Pharmaceuticals Inc, Key Ratios
Immune Pharmaceuticals Inc, Share Data
Immune Pharmaceuticals Inc, Major Products and Services
Immune Pharmaceuticals Inc, History
Immune Pharmaceuticals Inc, Key Employees
Immune Pharmaceuticals Inc, Key Employee Biographies
Immune Pharmaceuticals Inc, Key Operational Heads
Immune Pharmaceuticals Inc, Other Locations
Immune Pharmaceuticals Inc, Subsidiaries
Immune Pharmaceuticals Inc, Key Competitors
Immune Pharmaceuticals Inc, SWOT Analysis
Immune Pharmaceuticals Inc, Ratios based on current share price
Immune Pharmaceuticals Inc, Annual Ratios
Immune Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務情報
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Alberta Treasury Branches:企業の戦略的SWOT分析
    Alberta Treasury Branches - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner), a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer component …
  • CLAAS KGaA mbH:企業の戦略的SWOT分析
    CLAAS KGaA mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • General Mills Inc:企業のM&A・事業提携・投資動向
    General Mills Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's General Mills Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Young & Co.’s Brewery, P.L.C. (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery, P.L.C. (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Elron Electronic Industries Ltd (ELRNF)-医療機器分野:企業M&A・提携分析
    Summary Elron Electronic Industries Ltd (Elron), a subsidiary of IDB Holding Corp Ltd is a holding company that offers medical devices and technology solutions. The company offers patient care systems for stroke care, microbiology, age-related macular degeneration, orthopedics, and heart diseases. I …
  • Merit Medical Systems Inc (MMSI)-医療機器分野:企業M&A・提携分析
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Avantis Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company provides products such as single camera colonoscopy devices and third eye panoramic devices. Its third eye panoramic devices provide two side-viewing cameras supplement …
  • Proteostasis Therapeutics Inc (PTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteostasis Therapeutics Inc (Proteostasis) is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company’s portfolio spans drug candidates for cystic fibrosis, neurodegenerati …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務分析
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hitachi Metals, Ltd.:企業の戦略・SWOT・財務分析
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Consort Medical plc (CSRT):医療機器:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers t …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Seiko Epson Corp (6724):企業の財務・戦略的SWOT分析
    Seiko Epson Corp (6724) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Malakoff Corporation Berhad:発電所・企業SWOT分析
    Malakoff Corporation Berhad - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆